ES2337639T3 - Metodo para la liberacion cuantitativa de proteinas, polipeptidos o peptidos naturales o recombinantes. - Google Patents
Metodo para la liberacion cuantitativa de proteinas, polipeptidos o peptidos naturales o recombinantes. Download PDFInfo
- Publication number
- ES2337639T3 ES2337639T3 ES99928306T ES99928306T ES2337639T3 ES 2337639 T3 ES2337639 T3 ES 2337639T3 ES 99928306 T ES99928306 T ES 99928306T ES 99928306 T ES99928306 T ES 99928306T ES 2337639 T3 ES2337639 T3 ES 2337639T3
- Authority
- ES
- Spain
- Prior art keywords
- sample
- spa
- protein
- heating operation
- samples
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000034 method Methods 0.000 title claims abstract description 63
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 61
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 61
- 108090000765 processed proteins & peptides Proteins 0.000 title description 22
- 102000004196 processed proteins & peptides Human genes 0.000 title description 20
- 229920001184 polypeptide Polymers 0.000 title description 14
- 238000010438 heat treatment Methods 0.000 claims abstract description 40
- 239000000872 buffer Substances 0.000 claims abstract description 31
- 150000001875 compounds Chemical class 0.000 claims abstract description 13
- 108060003951 Immunoglobulin Proteins 0.000 claims abstract description 12
- 102000018358 immunoglobulin Human genes 0.000 claims abstract description 12
- 229940072221 immunoglobulins Drugs 0.000 claims abstract description 9
- 238000001816 cooling Methods 0.000 claims abstract description 7
- 238000002156 mixing Methods 0.000 claims abstract description 6
- 230000002209 hydrophobic effect Effects 0.000 claims abstract description 3
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 34
- 239000003153 chemical reaction reagent Substances 0.000 claims description 23
- 229910019142 PO4 Inorganic materials 0.000 claims description 8
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 8
- 239000010452 phosphate Substances 0.000 claims description 8
- 239000002738 chelating agent Substances 0.000 claims description 7
- 150000002500 ions Chemical class 0.000 claims description 7
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 claims description 3
- 229910001385 heavy metal Inorganic materials 0.000 claims description 3
- 239000000243 solution Substances 0.000 description 31
- 239000012895 dilution Substances 0.000 description 23
- 238000010790 dilution Methods 0.000 description 23
- 238000012360 testing method Methods 0.000 description 18
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 16
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 15
- 239000003446 ligand Substances 0.000 description 15
- 239000002953 phosphate buffered saline Substances 0.000 description 15
- 238000003556 assay Methods 0.000 description 14
- 238000002965 ELISA Methods 0.000 description 13
- 229920001213 Polysorbate 20 Polymers 0.000 description 12
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 12
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 12
- QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 description 11
- 210000002966 serum Anatomy 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 10
- 238000011084 recovery Methods 0.000 description 10
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 9
- 229940098773 bovine serum albumin Drugs 0.000 description 9
- 239000011780 sodium chloride Substances 0.000 description 8
- 238000004090 dissolution Methods 0.000 description 7
- 239000012460 protein solution Substances 0.000 description 7
- 230000009257 reactivity Effects 0.000 description 7
- 238000004153 renaturation Methods 0.000 description 7
- 238000001514 detection method Methods 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 230000002378 acidificating effect Effects 0.000 description 5
- 238000010494 dissociation reaction Methods 0.000 description 5
- 230000005593 dissociations Effects 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 238000011534 incubation Methods 0.000 description 5
- 239000011159 matrix material Substances 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 5
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 5
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 5
- 239000012898 sample dilution Substances 0.000 description 5
- 108010032595 Antibody Binding Sites Proteins 0.000 description 4
- 102000014914 Carrier Proteins Human genes 0.000 description 4
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 4
- 241000283973 Oryctolagus cuniculus Species 0.000 description 4
- 239000008351 acetate buffer Substances 0.000 description 4
- 125000003277 amino group Chemical group 0.000 description 4
- 108091008324 binding proteins Proteins 0.000 description 4
- 238000003018 immunoassay Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 229960003330 pentetic acid Drugs 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000001042 affinity chromatography Methods 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 239000000427 antigen Substances 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 230000003139 buffering effect Effects 0.000 description 3
- 239000000356 contaminant Substances 0.000 description 3
- 239000013024 dilution buffer Substances 0.000 description 3
- 230000007613 environmental effect Effects 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 230000000984 immunochemical effect Effects 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 238000010186 staining Methods 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- 239000011534 wash buffer Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 108010088751 Albumins Proteins 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 2
- 101100283604 Caenorhabditis elegans pigk-1 gene Proteins 0.000 description 2
- 108091006027 G proteins Proteins 0.000 description 2
- 102000030782 GTP binding Human genes 0.000 description 2
- 108091000058 GTP-Binding Proteins 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 108010058846 Ovalbumin Proteins 0.000 description 2
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 2
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000008033 biological extinction Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- -1 for example Chemical class 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 238000002523 gelfiltration Methods 0.000 description 2
- 229910001629 magnesium chloride Inorganic materials 0.000 description 2
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 2
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 238000003127 radioimmunoassay Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- JBFLYOLJRKJYNV-MASIZSFYSA-N (1z)-1-[(3,4-diethoxyphenyl)methylidene]-6,7-diethoxy-3,4-dihydro-2h-isoquinoline;hydron;chloride Chemical group Cl.C1=C(OCC)C(OCC)=CC=C1\C=C/1C2=CC(OCC)=C(OCC)C=C2CCN\1 JBFLYOLJRKJYNV-MASIZSFYSA-N 0.000 description 1
- YMXHPSHLTSZXKH-RVBZMBCESA-N (2,5-dioxopyrrolidin-1-yl) 5-[(3as,4s,6ar)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoate Chemical compound C([C@H]1[C@H]2NC(=O)N[C@H]2CS1)CCCC(=O)ON1C(=O)CCC1=O YMXHPSHLTSZXKH-RVBZMBCESA-N 0.000 description 1
- MIAKOEWBCMPCQR-YBXAARCKSA-N (2s,3r,4s,5r,6r)-2-(4-aminophenoxy)-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound C1=CC(N)=CC=C1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MIAKOEWBCMPCQR-YBXAARCKSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 239000010755 BS 2869 Class G Substances 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000282465 Canis Species 0.000 description 1
- 102000003780 Clusterin Human genes 0.000 description 1
- 108090000197 Clusterin Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 101100533558 Mus musculus Sipa1 gene Proteins 0.000 description 1
- 206010041925 Staphylococcal infections Diseases 0.000 description 1
- 101000582398 Staphylococcus aureus Replication initiation protein Proteins 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 101710120037 Toxin CcdB Proteins 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 230000008436 biogenesis Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N biotin Natural products N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000007975 buffered saline Substances 0.000 description 1
- 239000008366 buffered solution Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000012504 chromatography matrix Substances 0.000 description 1
- 230000009918 complex formation Effects 0.000 description 1
- 238000010668 complexation reaction Methods 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000003795 desorption Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- FMWAXKQEIXRUTI-UHFFFAOYSA-N dodecyl hydrogen sulfate;sodium Chemical compound [Na].CCCCCCCCCCCCOS(O)(=O)=O FMWAXKQEIXRUTI-UHFFFAOYSA-N 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000000147 enterotoxin Substances 0.000 description 1
- 231100000655 enterotoxin Toxicity 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 102000028557 immunoglobulin binding proteins Human genes 0.000 description 1
- 108091009323 immunoglobulin binding proteins Proteins 0.000 description 1
- 229940027941 immunoglobulin g Drugs 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000002297 mitogenic effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229940043515 other immunoglobulins in atc Drugs 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 230000007918 pathogenicity Effects 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 108010055837 phosphocarrier protein HPr Proteins 0.000 description 1
- 238000012529 protein A ELISA Methods 0.000 description 1
- 230000006920 protein precipitation Effects 0.000 description 1
- 238000001742 protein purification Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 238000003118 sandwich ELISA Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 238000011272 standard treatment Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 229920001187 thermosetting polymer Polymers 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/563—Immunoassay; Biospecific binding assay; Materials therefor involving antibody fragments
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/814—Enzyme separation or purification
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/961—Chemistry: molecular biology and microbiology including a step of forming, releasing, or exposing the antigen or forming the hapten-immunogenic carrier complex or the antigen per se
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/825—Pretreatment for removal of interfering factors from sample
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/826—Additives, e.g. buffers, diluents, preservatives
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
- Y10T436/25125—Digestion or removing interfering materials
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT106898 | 1998-06-19 | ||
| AT1068/98 | 1998-06-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2337639T3 true ES2337639T3 (es) | 2010-04-27 |
Family
ID=3505919
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES99928306T Expired - Lifetime ES2337639T3 (es) | 1998-06-19 | 1999-05-14 | Metodo para la liberacion cuantitativa de proteinas, polipeptidos o peptidos naturales o recombinantes. |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US6706486B1 (https=) |
| EP (1) | EP1088227B1 (https=) |
| JP (1) | JP4399115B2 (https=) |
| AT (1) | ATE452337T1 (https=) |
| DE (1) | DE69941815D1 (https=) |
| ES (1) | ES2337639T3 (https=) |
| WO (1) | WO1999066325A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003194775A (ja) * | 2001-12-28 | 2003-07-09 | Japan Science & Technology Corp | タンパク質の電気泳動法 |
| WO2008078809A1 (ja) * | 2006-12-27 | 2008-07-03 | Japan Science And Technology Agency | 鳥類抗体を使用する免疫学的検出方法 |
| WO2011093745A1 (en) * | 2010-01-26 | 2011-08-04 | Obschestvo S Ogranichennoi Otvetstvennostyu "Nauchno- Proizvodstvennaya Firma "Materia Medika Kholding" | Method of determination of autoantibody level by means of enzyme immunoassay |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4092114A (en) | 1976-10-20 | 1978-05-30 | Fisher Scientific Company | Indirect latex test for determination of immunoglobulins |
| SE448190B (sv) * | 1985-06-03 | 1987-01-26 | Pharmacia Ab | Sett att bestemma fc-dels-bindande bakteriella polypeptider |
| JP2791367B2 (ja) | 1988-04-21 | 1998-08-27 | マイクロプローブ・コーポレーション | 核酸抽出方法 |
| KR100230909B1 (ko) | 1993-11-29 | 1999-12-01 | 다니엘 엘. 캐시앙 | 광범위의 유기체로부터 핵산 추출 방법 |
| US5556745A (en) | 1994-06-03 | 1996-09-17 | Sch+E,Uml U+Ee Pbach; J+E,Uml O+Ee Rg | Method for the detection and quantitative determination of antigen in a test sample containing immune complexes of antigen bound to antibodies and to rheumatoid factors |
| AT403378B (de) * | 1995-09-11 | 1998-01-26 | Steindl Franz Dipl Ing Dr | Immun- und proteinkomplex-dissoziierung |
-
1999
- 1999-05-14 WO PCT/SE1999/000828 patent/WO1999066325A1/en not_active Ceased
- 1999-05-14 JP JP2000555093A patent/JP4399115B2/ja not_active Expired - Fee Related
- 1999-05-14 AT AT99928306T patent/ATE452337T1/de not_active IP Right Cessation
- 1999-05-14 DE DE69941815T patent/DE69941815D1/de not_active Expired - Lifetime
- 1999-05-14 ES ES99928306T patent/ES2337639T3/es not_active Expired - Lifetime
- 1999-05-14 US US09/719,512 patent/US6706486B1/en not_active Expired - Lifetime
- 1999-05-14 EP EP99928306A patent/EP1088227B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JP2002518675A (ja) | 2002-06-25 |
| EP1088227B1 (en) | 2009-12-16 |
| EP1088227A1 (en) | 2001-04-04 |
| ATE452337T1 (de) | 2010-01-15 |
| JP4399115B2 (ja) | 2010-01-13 |
| WO1999066325A1 (en) | 1999-12-23 |
| US6706486B1 (en) | 2004-03-16 |
| DE69941815D1 (de) | 2010-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0185870B2 (en) | Immunoassays for denatured protein analytes, particularly HB Alc, and monoclonal antibodies thereto | |
| Cederholm et al. | Circulating complexes containing IgA and fibronectin in patients with primary IgA nephropathy. | |
| Guzman et al. | Immunoaffinity CE for proteomics studies. | |
| ATE226633T1 (de) | Bindungsdomänen in notch- und delta-proteinen | |
| JPS62162963A (ja) | 金属コロイド粒子を担体とする低分子物質に対する特異抗体の作成法 | |
| KR100249752B1 (ko) | 항체의특정클래스에특이적인간섭억제시약 | |
| Goers et al. | The assembly of early components of complement on antibody-antigen aggregates and on antibody-coated erythrocytes | |
| Kaul et al. | Dissection of C1q capability of interacting with IgG: time-dependent formation of a tight and only partly reversible association | |
| ES2337639T3 (es) | Metodo para la liberacion cuantitativa de proteinas, polipeptidos o peptidos naturales o recombinantes. | |
| KR900700170A (ko) | 파라로그 어피니티 크로마토그라피 | |
| Herrmann et al. | Quantitation of immunoglobulin adsorption to plastics | |
| Klonisch et al. | Enhancement in antigen binding by a combination of synergy and antibody capture | |
| JPS6120815B2 (https=) | ||
| DE69921987D1 (de) | IMMUNTEST FÜR HUMAN CHROMOGRANINE A (CgA), ANTIKÖRPER, REAGENZ UND DAZU GEEIGNETER TESTSATZ | |
| Zikan | Interactions of pig Fab γ fragments with protein A from Staphylococcus aureus | |
| JPS58146855A (ja) | 免疫検定法 | |
| Peng et al. | Differential binding properties of protein A and protein G for dog immunoglobulins | |
| Schramm et al. | Surface modification with protein A for uniform binding of monoclonal antibodies. | |
| Ylikotila et al. | Improved surface stability and biotin binding properties of streptavidin coating on polystyrene | |
| Staak et al. | Polystyrene as an affinity chromatography matrix for the purification of antibodies | |
| Lotter et al. | Antigenic Structure of the Cyanogen Bromide Peptide F‐CB3 from Fibrinogen‐Chain | |
| Parker | [53] Immunoassays | |
| Chaffotte et al. | Immunochemical evidence for conformational flexibility and its modulation by specific ligands in the. beta. 2 subunit of Escherichia coli tryptophan synthase | |
| Bruin et al. | Binding of Human IgA Fragments to Protein A‐Sepharose Studied with an ELISA Method | |
| ES2197425T3 (es) | Superficies union a ligando. |